Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation

Fig. 3

Assessment of voiding function. A Cystometrography curves of the different groups at 2, 4, and 6 weeks. B, C Statistical results of maximal voiding pressure and intercontraction interval showed that iMSCs-EVs administration significantly reduced the voiding pressure and the increased intercontraction interval at 4 weeks. These parameters reached a normal level at 6 weeks. Data are presented as the mean ± SD, *P < 0.05, n.s. indicates no significance

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512